Selected research
Industry Growth & Trends
Global Quetiapine Fumarate Tablets Industry Growth and Trends Forecast to 2032
Market perspective
The global Quetiapine Fumarate Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Quetiapine Fumarate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Quetiapine Fumarate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Quetiapine Fumarate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Quetiapine Fumarate Tablets include Teva Pharmaceuticals, Sun Pharma, Sandoz, Lupin Limited, Hunan Dongting Pharmaceutical, Hikma, Dr. Reddy's Laboratories, AstraZeneca and Alkem Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Quetiapine Fumarate Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Quetiapine Fumarate Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Quetiapine Fumarate Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Quetiapine Fumarate Tablets.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Quetiapine Fumarate Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Quetiapine Fumarate Tablets Market by Company
Teva Pharmaceuticals
Sun Pharma
Sandoz
Lupin Limited
Hunan Dongting Pharmaceutical
Hikma
Dr. Reddy's Laboratories
AstraZeneca
Alkem Laboratories
Quetiapine Fumarate Tablets Segment by Type
0.2g
0.3g
Others
Quetiapine Fumarate Tablets Segment by Application
Hospital
Clinic
Others
Quetiapine Fumarate Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Quetiapine Fumarate Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Quetiapine Fumarate Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Quetiapine Fumarate Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Quetiapine Fumarate Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Quetiapine Fumarate Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.2g
- 0.3g
- Others
Applications
- Hospital
- Clinic
- Others
Companies covered
- Teva Pharmaceuticals
- Sun Pharma
- Sandoz
- Lupin Limited
- Hunan Dongting Pharmaceutical
- Hikma
- Dr. Reddy's Laboratories
- AstraZeneca
- Alkem Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Quetiapine Fumarate Tablets Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Quetiapine Fumarate Tablets Sales Estimates and Forecasts (2021-2032)
- 1.3 Quetiapine Fumarate Tablets Market by Type
- 1.3.1 0.2g
- 1.3.2 0.3g
- 1.3.3 Others
- 1.4 Global Quetiapine Fumarate Tablets Market Size by Type
- 1.4.1 Global Quetiapine Fumarate Tablets Market Size Overview by Type (2021-2032)
- 1.4.2 Global Quetiapine Fumarate Tablets Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Quetiapine Fumarate Tablets Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Quetiapine Fumarate Tablets Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Quetiapine Fumarate Tablets Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Quetiapine Fumarate Tablets Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Quetiapine Fumarate Tablets Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Quetiapine Fumarate Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Quetiapine Fumarate Tablets Industry Trends
- 2.2 Quetiapine Fumarate Tablets Industry Drivers
- 2.3 Quetiapine Fumarate Tablets Industry Opportunities and Challenges
- 2.4 Quetiapine Fumarate Tablets Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Quetiapine Fumarate Tablets Revenue (2021-2026)
- 3.2 Global Top Players by Quetiapine Fumarate Tablets Sales (2021-2026)
- 3.3 Global Top Players by Quetiapine Fumarate Tablets Price (2021-2026)
- 3.4 Global Quetiapine Fumarate Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Quetiapine Fumarate Tablets Major Company Production Sites & Headquarters
- 3.6 Global Quetiapine Fumarate Tablets Company, Product Type & Application
- 3.7 Global Quetiapine Fumarate Tablets Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Quetiapine Fumarate Tablets Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Quetiapine Fumarate Tablets Players Market Share by Revenue in 2025
- 3.8.3 2025 Quetiapine Fumarate Tablets Tier 1, Tier 2, and Tier 3
4 Quetiapine Fumarate Tablets Regional Status and Outlook
- 4.1 Global Quetiapine Fumarate Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Quetiapine Fumarate Tablets Historic Market Size by Region
- 4.2.1 Global Quetiapine Fumarate Tablets Sales in Volume by Region (2021-2026)
- 4.2.2 Global Quetiapine Fumarate Tablets Sales in Value by Region (2021-2026)
- 4.2.3 Global Quetiapine Fumarate Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Quetiapine Fumarate Tablets Forecasted Market Size by Region
- 4.3.1 Global Quetiapine Fumarate Tablets Sales in Volume by Region (2027-2032)
- 4.3.2 Global Quetiapine Fumarate Tablets Sales in Value by Region (2027-2032)
- 4.3.3 Global Quetiapine Fumarate Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Quetiapine Fumarate Tablets by Application
- 5.1 Quetiapine Fumarate Tablets Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Quetiapine Fumarate Tablets Market Size by Application
- 5.2.1 Global Quetiapine Fumarate Tablets Market Size Overview by Application (2021-2032)
- 5.2.2 Global Quetiapine Fumarate Tablets Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Quetiapine Fumarate Tablets Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Quetiapine Fumarate Tablets Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Quetiapine Fumarate Tablets Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Quetiapine Fumarate Tablets Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Quetiapine Fumarate Tablets Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Quetiapine Fumarate Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Teva Pharmaceuticals
- 6.1.1 Teva Pharmaceuticals Company Information
- 6.1.2 Teva Pharmaceuticals Business Overview
- 6.1.3 Teva Pharmaceuticals Quetiapine Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Teva Pharmaceuticals Quetiapine Fumarate Tablets Product Portfolio
- 6.1.5 Teva Pharmaceuticals Recent Developments
- 6.2 Sun Pharma
- 6.2.1 Sun Pharma Company Information
- 6.2.2 Sun Pharma Business Overview
- 6.2.3 Sun Pharma Quetiapine Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Sun Pharma Quetiapine Fumarate Tablets Product Portfolio
- 6.2.5 Sun Pharma Recent Developments
- 6.3 Sandoz
- 6.3.1 Sandoz Company Information
- 6.3.2 Sandoz Business Overview
- 6.3.3 Sandoz Quetiapine Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Sandoz Quetiapine Fumarate Tablets Product Portfolio
- 6.3.5 Sandoz Recent Developments
- 6.4 Lupin Limited
- 6.4.1 Lupin Limited Company Information
- 6.4.2 Lupin Limited Business Overview
- 6.4.3 Lupin Limited Quetiapine Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Lupin Limited Quetiapine Fumarate Tablets Product Portfolio
- 6.4.5 Lupin Limited Recent Developments
- 6.5 Hunan Dongting Pharmaceutical
- 6.5.1 Hunan Dongting Pharmaceutical Company Information
- 6.5.2 Hunan Dongting Pharmaceutical Business Overview
- 6.5.3 Hunan Dongting Pharmaceutical Quetiapine Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Hunan Dongting Pharmaceutical Quetiapine Fumarate Tablets Product Portfolio
- 6.5.5 Hunan Dongting Pharmaceutical Recent Developments
- 6.6 Hikma
- 6.6.1 Hikma Company Information
- 6.6.2 Hikma Business Overview
- 6.6.3 Hikma Quetiapine Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Hikma Quetiapine Fumarate Tablets Product Portfolio
- 6.6.5 Hikma Recent Developments
- 6.7 Dr. Reddy's Laboratories
- 6.7.1 Dr. Reddy's Laboratories Company Information
- 6.7.2 Dr. Reddy's Laboratories Business Overview
- 6.7.3 Dr. Reddy's Laboratories Quetiapine Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Dr. Reddy's Laboratories Quetiapine Fumarate Tablets Product Portfolio
- 6.7.5 Dr. Reddy's Laboratories Recent Developments
- 6.8 AstraZeneca
- 6.8.1 AstraZeneca Company Information
- 6.8.2 AstraZeneca Business Overview
- 6.8.3 AstraZeneca Quetiapine Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 AstraZeneca Quetiapine Fumarate Tablets Product Portfolio
- 6.8.5 AstraZeneca Recent Developments
- 6.9 Alkem Laboratories
- 6.9.1 Alkem Laboratories Company Information
- 6.9.2 Alkem Laboratories Business Overview
- 6.9.3 Alkem Laboratories Quetiapine Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Alkem Laboratories Quetiapine Fumarate Tablets Product Portfolio
- 6.9.5 Alkem Laboratories Recent Developments
7 North America by Country
- 7.1 North America Quetiapine Fumarate Tablets Sales by Country
- 7.1.1 North America Quetiapine Fumarate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Quetiapine Fumarate Tablets Sales by Country (2021-2026)
- 7.1.3 North America Quetiapine Fumarate Tablets Sales Forecast by Country (2027-2032)
- 7.2 North America Quetiapine Fumarate Tablets Market Size by Country
- 7.2.1 North America Quetiapine Fumarate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Quetiapine Fumarate Tablets Market Size by Country (2021-2026)
- 7.2.3 North America Quetiapine Fumarate Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Quetiapine Fumarate Tablets Sales by Country
- 8.1.1 Europe Quetiapine Fumarate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Quetiapine Fumarate Tablets Sales by Country (2021-2026)
- 8.1.3 Europe Quetiapine Fumarate Tablets Sales Forecast by Country (2027-2032)
- 8.2 Europe Quetiapine Fumarate Tablets Market Size by Country
- 8.2.1 Europe Quetiapine Fumarate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Quetiapine Fumarate Tablets Market Size by Country (2021-2026)
- 8.2.3 Europe Quetiapine Fumarate Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Quetiapine Fumarate Tablets Sales by Country
- 9.1.1 Asia-Pacific Quetiapine Fumarate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Quetiapine Fumarate Tablets Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Quetiapine Fumarate Tablets Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Quetiapine Fumarate Tablets Market Size by Country
- 9.2.1 Asia-Pacific Quetiapine Fumarate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Quetiapine Fumarate Tablets Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Quetiapine Fumarate Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Quetiapine Fumarate Tablets Sales by Country
- 10.1.1 South America Quetiapine Fumarate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Quetiapine Fumarate Tablets Sales by Country (2021-2026)
- 10.1.3 South America Quetiapine Fumarate Tablets Sales Forecast by Country (2027-2032)
- 10.2 South America Quetiapine Fumarate Tablets Market Size by Country
- 10.2.1 South America Quetiapine Fumarate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Quetiapine Fumarate Tablets Market Size by Country (2021-2026)
- 10.2.3 South America Quetiapine Fumarate Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Quetiapine Fumarate Tablets Sales by Country
- 11.1.1 Middle East and Africa Quetiapine Fumarate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Quetiapine Fumarate Tablets Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Quetiapine Fumarate Tablets Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Quetiapine Fumarate Tablets Market Size by Country
- 11.2.1 Middle East and Africa Quetiapine Fumarate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Quetiapine Fumarate Tablets Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Quetiapine Fumarate Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Quetiapine Fumarate Tablets Value Chain Analysis
- 12.1.1 Quetiapine Fumarate Tablets Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Quetiapine Fumarate Tablets Production Mode & Process
- 12.2 Quetiapine Fumarate Tablets Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Quetiapine Fumarate Tablets Distributors
- 12.2.3 Quetiapine Fumarate Tablets Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst